Ranibizumab improves vision-related function in neovascular AMD

Reuters Health"Ranibizumab produces 'meaningful' improvements in vision-related function and quality of life in patients with neovascular age-related macular degeneration (AMD), according to a report in the November issue of the Archives of Ophthalmology. 'This is the first time that we have been able to demonstrate a statistically and clinically significant increase in vision-related quality of life in patients treated for wet AMD,' Dr. Tom S. Chang from the Retina Institute of California, Pasadena, told Reuters Health. "